Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Summary

Brief Summary: The primary objective was: * to assess the bioequivalence of a single dose (two inhalations) of the test product compared to the reference product, with and without charcoal blockade. The secondary objectives were: * to assess the pharmacokinetic profile of budesonide and formoterol in plasma after a single dose (two inhalations) of the test product and the reference product, with and without charcoal blockade. * to assess the safety and tolerability of the test product and the reference product, with and without charcoal blockade.

Timeline

Start

2016-01

Primary completion

2016-07

Completion

2016-07

Drugs

Indications